Klaruktam® AF 1000 mg + 500 mg – an original combination of cefotaxime and sulbactam for the treatment of community-acquired infections in hospital settings, as well as for perioperative prophylaxis.

Trade name: Klaruktam®
International Nonproprietary Name: cefotaxime + [sulbactam]
Marketing Authorisation Holder: ALFARMA LLC (Russia)
Manufactured by: RUZFARMA LLC (Russia)
Packaging and final quality control: RUZFARMA LLC (Russia) or ALTEGRA JSC (Russia)
Dosage form: powder for preparation of solution for intravenous and intramuscular injection.
Composition per vial: Active ingredients: cefotaxime 1000.0 mg (as cefotaxime sodium 1048.0 mg), sulbactam 500.0 mg (as sulbactam sodium 547.0 mg)․ Excipients: none.
Pharmacotherapeutic group: antibacterial agents for systemic use; other beta-lactam antibacterials; third-generation cephalosporins.
ATC code: J01DD51

044221612

mirarpharm@gmail.com

ՀՀ, Երևան, Թումանյան փ․ 35/11